Entries in Glaucoma (5)

Friday
May312013

New Link Between Glucosamine and Glaucoma

Image courtesy of wisegeek.com

A new link between the oral supplement, glucosamine, and glaucoma has been found in a new, small study published as aresearch letter in The Journal of the American Medical Association. The study was done with 17 participants all over the age of 76.

Specifically, the study found:

Overall, pressure inside the eye was higher when participants were taking glucosamine, but did return to normal after they stopped taking these supplements, the study showed.

"This study shows a reversible effect of these changes, which is reassuring," wrote researchers led by Dr. Ryan Murphy at the University of New England College of Osteopathic Medicine in Biddeford, Maine. "However, the possibility that permanent damage can result from prolonged use of glucosamine supplementation is not eliminated. Monitoring IOP in patients choosing to supplement with glucosamine may be indicated."

U.S. News and World Report noted that while this was the first time this link has been made, the study was limited in terms of brand and duration of the supplement. 

Read the Research Letter: Oral Glucosamine Supplements as a Possible Ocular Hypertensive Agent

Read the U.S. News and World Report Article: Glucosamine Supplements Tied to Risk of Eye Condition

Wednesday
May292013

The Economic Costs of Age-Related Eye Disease

Image courtesy of wfsb.com

The American Journal of Managed Care published an online supplement by William J. Cardarelli, PharmD and Roderick A. Smith, MS discussing the current economic effects and costs of eye disease as it related to our aging population in the U.S. Areas covered include Open-Angle Glaucoma, Wet AMD, and Dry Eye Disease.

The authors concluded the following:

The trend of rising costs associated with visual impairment and the treatment of age-related ocular diseases in the United States is having a tremendous impact on patients’ caregivers, third-party payers, and society. These costs will almost certainly continue to increase in the coming decades as the baby boomer generation reaches old age. While new treatments for eye diseases are benefiting thousands of patients, the costs of these treatments are a major cause of concern.

Read the Article: Managed Care Implications of Age-Related Ocular Conditions

Friday
Mar082013

Glaucoma Affects Hundreds of Thousands in Ghana

Image courtesy of modernghana.com
Various news service outlets in Ghana reported that 700,000 Ghanaians are currently living with glaucoma. Experts believe about 250,000 cases have gone undiagnosed.
Dr. Harrison Kofi Abutiate, National President of the Glaucoma Association of Ghana, presented these findings as a launch of Glaucoma Week in Ghana.
"He called for partnership from cell phone operators to send awareness creation messages regularly to the public as a reminder to regularly check their eyes for glaucoma in addition to financial support from both government and private institutions to help in creating the needed awareness to fight glaucoma in Ghana."
The Duke Eye Center is currently looking at isolating a possible glaucoma gene in Ghana. More about this work can be read here.
Tuesday
Jan152013

January is Glaucoma Awareness Month: Statement from NEI Director Dr. Paul A. Sieving 

National Eye Institute (NEI) Director Dr. Paul A. Sieving released a statement in conjunction with Glaucoma Awareness Month, stating the pressing need for Americans to receive dilated eye exams once every one to two years. 

Read the full statement here.
Tuesday
Sep252012

ORSF Visits the Vanderbilt Eye Institute

Dr. David Calkins invited ORSF Board President Delta Wright to the Vanderbilt Eye Institute 2012 symposium, “Regenerative Medicine in Glaucoma” that took place in Nashville, Tennesse September 20-21 at the Vanderbilt Marriott Hotel. The institute's intent was to "foster new advances in our understanding of the neural basis for vision loss in glaucoma and how regenerative and rehabilitative medicine could lend themselves as promising approaches to a cure."  

More information on the symposium can be found here: